Stay updated on Tepotinib Phase II Clinical Trial

Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib Phase II Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Substantive content did not change; the two screenshots show the same Study Details page for NCT02864992 with no additions or deletions to the core content.
    Difference
    0.2%
    Check dated 2025-11-03T21:31:19.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T07:57:52.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-29T04:27:49.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed. Overall, a minor maintenance update with no substantive changes to core content, pricing, or stock.
    Difference
    0.1%
    Check dated 2025-09-14T22:15:52.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T19:40:50.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as detailed information on cancer treatments and clinical trials, particularly focusing on tepotinib for non-small cell lung cancer. Several previous entries related to locations and cancer types have been removed.
    Difference
    17%
    Check dated 2025-08-31T12:31:08.000Z thumbnail image

Stay in the know with updates to Tepotinib Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.